LEVELS OF TERBINAFINE IN PLASMA, STRATUM-CORNEUM, DERMIS EPIDERMIS (WITHOUT STRATUM-CORNEUM), SEBUM, HAIR AND NAILS DURING AND AFTER 250 MGTERBINAFINE ORALLY ONCE-DAILY FOR 7 AND 14 DAYS
J. Faergemann et al., LEVELS OF TERBINAFINE IN PLASMA, STRATUM-CORNEUM, DERMIS EPIDERMIS (WITHOUT STRATUM-CORNEUM), SEBUM, HAIR AND NAILS DURING AND AFTER 250 MGTERBINAFINE ORALLY ONCE-DAILY FOR 7 AND 14 DAYS, Clinical and experimental dermatology, 19(2), 1994, pp. 121-126
In earlier skin pharmacokinetic studies we have shown that terbinafine
is rapidly delivered to the stratum corneum, nails and hair both thro
ugh sebum and by direct diffusion through dermis-epidermis. In the pre
sent study the skin pharmacokinetic profile of terbinafine was studied
in two groups of eight human male volunteers during and after 250 mg
orally once daily for 7 and 14 days. In the 7-day study high terbinafi
ne levels were found in sebum (19.0 mug/g) and stratum corneum (2.5 mu
g/g), and a concentration in stratum corneum above the minimal inhibit
ory concentration for most dermatophytes was still found 48 days after
the last day of medication. Terbinafine was found in peripheral nail
clippings after 7 days of medication and the concentration was, in the
7-day study, 0.5 mug/g 1 day after stopping medication; it was still
0.2 mug/g 90 days after stopping treatment. The results in the 14-day
study were in parallel with, but higher than, in the 7-day study. The
elimination of terbinafine from several compartments is biphasic, with
a faster initial elimination followed by a slower secondary eliminati
on. For nails, the elimination is slower compared with the other compa
rtments. The results indicate that terbinafine may be effective in sho
rt-term treatment of several dermatophytoses. The concentration of 0.2
mug/g of terbinafine found in nails 90 days after stopping medication
, following 7 days of treatment, indicates that the duration of therap
y, even in tinea ungium, may be shorter than is currently the case.